It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
This explainer defines global market indices, explains their purpose, and outlines how they aggregate data from multiple markets.
27,297 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...
A major corporate Bitcoin holder expands its BTC stake during a market pullback, widening unrealized losses but under...
Stanley Martin Homes will acquire United Homes Group in an all-cash deal valued at $221 million, taking UHG private a...
Four AI models project XRP’s 2026 end price in a wide band, signaling divergent bets on Ripple’s payment ambitions an...
A wave of new analyst ratings hits screens Friday, touching auto parts, semiconductors, software and biotech. Upgrade...
When a founder dumps stock, investors naturally pause. This article explains what the Lindblad Expeditions sell after...
Oil headlines have surged, but MPLX has moved differently. This article breaks down two critical takeaways for invest...
U.S. policymakers confront a volatile oil backdrop and rising pump prices, weighing reserves, production, and demand ...
Micron Technology stunned investors with a massive quarterly upside. This article breaks down why micron technology's...
The AI boom is reshaping the chip landscape. This guide identifies the best chips stocks right now and shows investor...